Premier Value Arthritis Pain Reliever
NDC Package 68016-340-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Premier Value Arthritis Pain Reliever is •do not take more than directed (see overdose warning) adults ▪ take 2 geltabs every 8 hours. Marketed by Chain Drug Consortium, Llc, this product is identified by NDC 68016-340 and is authorized under FDA application ANDA078569.

Identification & Billing

NDC Package Code
68016-340-08
Package Description
80 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
68016-340
11-Digit Billing Format
68016034008
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
80 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Premier Value Arthritis Pain Reliever
Dosage Form
-
Usage Information
•do not take more than directed (see overdose warning) adults ▪ take 2 geltabs every 8 hours. Swallow only one geltab at a time. ▪ take a sip of water before swallowing each geltab and wash each geltab down with water (up to a full 8 oz. glass). ▪ swallow whole - do not crush, chew, split or dissolve ▪ do not take more than 6 geltabs in 24 hours ▪ do not use for more than 10 days unless directed by a doctor under 18 years of age ▪ ask a doctor

Regulatory & Marketing

Labeler Name
Chain Drug Consortium, Llc
FDA Application #
ANDA078569
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-21-2012
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (68016-340). Click a package code to view its specific billing and regulatory data.

68016-340-40
40 TABLET, EXTENDED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68016-340-08 identifies a specific commercial package of 80 tablet, extended release in 1 bottle of Premier Value Arthritis Pain Reliever, labeled by Chain Drug Consortium, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 80 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Consortium, Llc on December 21, 2012. The current certification is valid through December 31, 2019.

How is this Chain Drug Consortium, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016034008. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 80 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68016-340-08
11-Digit CMS (5-4-2)
68016-0340-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.